Kestra Medical Technologies, Ltd.

KMTS Nasdaq SEC CIK 1877184
Follow Kestra Medical Technologies, Ltd. Weekly email: filings, results

Financials

Reported figures only · latest: Q1 2027 USD · US GAAP
Revenue, last quarter $31M +59.9% vs same quarter last year
Net income −$44.1M −70.7% vs same quarter last year
EPS, diluted −$0.75 −50% vs same quarter last year
Operating cash flow −$32.3M −22.9% vs same quarter last year
Revenue by quarter
$14.7M
$15.1M
$17.2M
$19.4M
$22.6M
$24.6M
$28.6M
$31M
Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26 Q4 26 Q1 27

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income4 fiscal years
  • Revenue
  • Net income
−$200M−$100M$0$100MFY23FY24FY25FY26
Show the numbers
YearRevenueNet income
FY26$95.1M−$131.6M
FY25$59.8M−$113.8M
FY24$27.8M−$94.1M
FY23--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−400%−300%−200%−100%0%100%FY23FY24FY25FY26
Show the numbers
YearGross marginOperating marginNet margin
FY2651.4%−141.6%−138.4%
FY2540.5%−177.8%−190.3%
FY241.3%−305.8%−338.4%
FY23---
Free cash flowOperating cash flow minus capital expenditure
−$150M−$100M−$50M$0FY23FY24FY25FY26
Show the numbers
YearFree cash flow
FY26−$116.6M
FY25−$100.5M
FY24−$84.5M
FY23-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Kestra Medical Technologies, Ltd.
  • Healthcare median
−400%−300%−200%−100%0%FY23FY24FY25FY26
Show the numbers
YearKestra Medical Technologies, Ltd.Healthcare median
FY26−138.4%−11.1%
FY25−190.3%−30.6%
FY24−338.4%−47%
FY23-−58%